These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19249691)

  • 1. Are hemodynamic parameters predictors of mortality?
    Haas GJ; Leier CV
    Heart Fail Clin; 2009 Apr; 5(2):229-40. PubMed ID: 19249691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The treatment targets in acute decompensated heart failure.
    Fonarow GC
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S7-S12. PubMed ID: 12439356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of B-type natriuretic peptide levels in predicting hemodynamic and clinical decompensation.
    Taub PR; Daniels LB; Maisel AS
    Heart Fail Clin; 2009 Apr; 5(2):169-75. PubMed ID: 19249686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
    Groden DL
    Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute decompensated heart failure: challenges and opportunities.
    Fonarow GC
    Rev Cardiovasc Med; 2007; 8 Suppl 5():S3-12. PubMed ID: 18192951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a review. III. Angiotensin-converting enzyme inhibitors.
    Ascenção R; Fortuna P; Reis I; Carneiro AV
    Rev Port Cardiol; 2008 Sep; 27(9):1169-87. PubMed ID: 19044179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing outcomes in the patient with acute decompensated heart failure.
    Mehra MR
    Am Heart J; 2006 Mar; 151(3):571-9. PubMed ID: 16504617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic evaluation in patients with heart failure].
    Vizzardi E; Nodari S; Fiorina C; Procopio R; Trussardi E; D'Aloia A; Rocca P; Metra M; Dei Cas L
    Ital Heart J Suppl; 2003 Sep; 4(9):720-6. PubMed ID: 14635389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium nitroprusside for advanced low-output heart failure.
    Mullens W; Abrahams Z; Francis GS; Skouri HN; Starling RC; Young JB; Taylor DO; Tang WH
    J Am Coll Cardiol; 2008 Jul; 52(3):200-7. PubMed ID: 18617068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current approaches to monitoring and management of heart failure.
    Yancy CW
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S25-32. PubMed ID: 16955057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia.
    Palazzuoli A; Silverberg DS; Calabrò A; Spinelli T; Quatrini I; Campagna MS; Franci B; Nuti R
    J Cardiovasc Pharmacol; 2009 Jun; 53(6):462-7. PubMed ID: 19455052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term hemodynamic effects of cardiac resynchronization therapy in patients with heart failure, a narrow QRS duration, and no dyssynchrony.
    Williams LK; Ellery S; Patel K; Leyva F; Bleasdale RA; Phan TT; Stegemann B; Paul V; Steendijk P; Frenneaux M
    Circulation; 2009 Oct; 120(17):1687-94. PubMed ID: 19822812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of vasoactive therapy for acute decompensated heart failure: hemodynamic and renal considerations.
    Heywood JT; Khan TA
    Rev Cardiovasc Med; 2007; 8 Suppl 5():S22-9. PubMed ID: 18192950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should we inhibit angiotensin-converting enzymes in acute heart failure?
    Lamond NW; Howlett JG
    Heart Fail Monit; 2007; 5(3):70-6. PubMed ID: 17487295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic accuracy and clinical relevance of brain natriuretic peptide assay in pediatric patients with congenital heart diseases.
    Cantinotti M; Vittorini S; Storti S; Prontera C; Murzi M; De Lucia V; Recla S; Assanta N; Giusti S; Murzi B; Bottone U; Clerico A
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):706-13. PubMed ID: 19444132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma brain natriuretic peptide-guided therapy not yet justified.
    Hoppe UC
    J Am Coll Cardiol; 2007 Nov; 50(21):2097-8; author reply 2098-9. PubMed ID: 18021882
    [No Abstract]   [Full Text] [Related]  

  • 17. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure.
    Parekh N; Maisel AS
    Curr Opin Cardiol; 2009 Mar; 24(2):155-60. PubMed ID: 19532102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal brain natriuretic peptide as a diagnostic test in cirrhotic patients with pulmonary arterial hypertension.
    Bernal V; Pascual I; Esquivias P; García-Gil A; Mateo JM; Lacambra I; Serrano MT; Simón MA
    Transplant Proc; 2009 Apr; 41(3):987-8. PubMed ID: 19376405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanistic interaction remains to be determined for elevated NTproBNP in heart failure patients receiving both an ACE inhibitor and aspirin.
    McLachlan CS; Zhang Z; Mossop P
    J Card Fail; 2007 Feb; 13(1):75-6. PubMed ID: 17339006
    [No Abstract]   [Full Text] [Related]  

  • 20. Congestion in acute heart failure syndromes: importance of early recognition and treatment.
    De Luca L; Abraham WT; Fonarow GC; Gheorghiade M
    Rev Cardiovasc Med; 2006; 7(2):69-74. PubMed ID: 16915125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.